COMP <GO>
SGHT vs MDXG // EV/EBITDA & P/E VALUATION
Sight Sciences Inc. (NASDAQ) VS. MiMedx Group Inc (NASDAQ) • 15-METRIC TALLY: SGHT 2
— MDXG 8
■ METRIC PARITY
LAST: $9.57 (+3.57%) • MKT CAP: $527.2M
valuation
—
LAST: $3.97 (+0.51%) • MKT CAP: $579.3M
valuation
6.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGHT VS. MDXG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGHT | MDXG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.20% | 82.60% | +3.60 | SGHT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 47.20% | -82.20 | MDXG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 6.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.67% | 12.77% | -18.44 | MDXG | /fcf-yield <GO> |
| Operating Margin | -48.00% | 15.30% | -63.30 | MDXG | /operating-margins <GO> |
| Net Profit Margin | -49.70% | 11.60% | -61.30 | MDXG | /net-margins <GO> |
| Revenue Growth (YoY) | -3.10% | 20.00% | -23.10 | MDXG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.16 | 6.45 | -4.29 | MDXG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | MDXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 32.9 | +26.43 | SGHT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 10.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $527.2M | $579.3M | -$52.1M | MDXG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGHT REV | MDXG REV | SGHT GROSS % | MDXG GROSS % | SGHT FCF | MDXG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $77.4M | $418.6M | 86.2% | 82.6% | -$29.9M | $74.0M |
| FY 2024 | $79.9M | $348.9M | 85.5% | 82.8% | -$22.7M | $66.2M |
| FY 2023 | $81.1M | $321.5M | — | — | -$47.2M | $26.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGHT // BETA —
MDXG // BETA —